Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide versus duloxetine for taxane-induced peripheral neuropathy
IRCT20090613002027N21Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of lacosamide and duloxetine in peripheral neuropathy (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: Efficacy of lacosamide versus duloxetine and Safety of lacosamide versus duloxetine. Started May 2023; status: completed.
02
Drugs
lacosamideduloxetine
03
Conditions
peripheral neuropathy
Beyond the preview
Go deeper on IRCT20090613002027N21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090613002027N21.